Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Pal

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Chemmedchem|February 19, 2024
Accelerating BRPF1b hit identification with BioPhysical and Active Learning Screening (BioPALS)Sandeep Pal, Zandile Nare, Vincenzo A Rao, et al.
Journal of Clinical and Diagnostic Research : JCDR|March 5, 2015
Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical TrialB S Chandrashekhar, M Anitha, Mukesh Ruparelia, et al.
Biochemistry|March 28, 2012
Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesisAlexander Heifetz, G Benjamin Morris, Philip C Biggin, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
ACS Chemical Biology|November 30, 2017
Design and Application of a DNA-Encoded Macrocyclic Peptide LibraryZhengrong Zhu, Alex Shaginian, LaShadric C Grady, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Chemmedchem|February 19, 2024
Accelerating BRPF1b hit identification with BioPhysical and Active Learning Screening (BioPALS)Sandeep Pal, Zandile Nare, Vincenzo A Rao, et al.
Journal of Clinical and Diagnostic Research : JCDR|March 5, 2015
Tretinoin Nanogel 0.025% Versus Conventional Gel 0.025% in Patients with Acne Vulgaris: A Randomized, Active Controlled, Multicentre, Parallel Group, Phase IV Clinical TrialB S Chandrashekhar, M Anitha, Mukesh Ruparelia, et al.
Biochemistry|March 28, 2012
Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesisAlexander Heifetz, G Benjamin Morris, Philip C Biggin, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
ACS Chemical Biology|November 30, 2017
Design and Application of a DNA-Encoded Macrocyclic Peptide LibraryZhengrong Zhu, Alex Shaginian, LaShadric C Grady, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
Pageof 3